| Financial Year |
March 31 2023 |
| Monetary Funds |
329,405,744.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
43,428,161.30 |
| Advances to Suppliers |
34,857,717.18 |
| Other Receivables |
1,256,886.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
79,608,169.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,642,990.21 |
| Total Current Assets |
526,418,557.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
164,199,747.32 |
| Investment Properties |
-- |
| Fixed Assetes |
529,700,522.71 |
| Under-construction Projects |
90,611,256.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,205,731.87 |
| R&D expenses |
63,878,026.79 |
| Goodwill |
58,968,390.42 |
| Long-Term Deferred and Prepaid Expenses |
37,472,335.40 |
| Deferred Income Tax Assets |
82,573,308.86 |
| Other Non-Current Assets |
69,729,908.30 |
| Sub-Total of Non-Current Assets |
1,192,696,556.73 |
| Total Assets |
1,719,115,113.73 |
| Short-Term Loans |
187,253,026.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,558,000.00 |
| Accounts Payable |
104,967,568.50 |
| Accounts Received In Advance |
3,853.22 |
| Employee Compensation Payable |
6,141,984.47 |
| Taxes Payable |
7,222,614.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,381,873.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,993,492.88 |
| Other Current Liabilities |
652,143.45 |
| Sub-Total of Current Liabilities |
380,422,270.11 |
| Long-term Loans |
185,337,100.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,259,329.36 |
| Deferred Income Tax Liabilities |
2,298,044.63 |
| Other Non-Current Liabilities |
223,862,222.22 |
| Sub-Total of Non-Current Liabilities |
453,633,856.47 |
| Total Liabilities |
834,056,126.58 |
| Paid-In Capital(Or Share Stock) |
159,267,000.00 |
| Capital Surplus |
611,691,195.21 |
| Surplus Reserve |
44,393,833.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-9,822,824.24 |
| Minority Stockholder's Interest |
79,529,782.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
805,529,204.28 |
| Owner's Equity（Stockholder's Equity） |
885,058,987.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,719,115,113.73 |
